These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 15925832)
1. Role of intramolecular epitope spreading in pemphigus vulgaris. Salato VK; Hacker-Foegen MK; Lazarova Z; Fairley JA; Lin MS Clin Immunol; 2005 Jul; 116(1):54-64. PubMed ID: 15925832 [TBL] [Abstract][Full Text] [Related]
2. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453 [TBL] [Abstract][Full Text] [Related]
3. IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris. Müller R; Svoboda V; Wenzel E; Müller HH; Hertl M Exp Dermatol; 2008 Jan; 17(1):35-43. PubMed ID: 18095943 [TBL] [Abstract][Full Text] [Related]
4. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris. Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525 [TBL] [Abstract][Full Text] [Related]
5. IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris. Müller R; Svoboda V; Wenzel E; Gebert S; Hunzelmann N; Müller HH; Hertl M Exp Dermatol; 2006 Aug; 15(8):606-14. PubMed ID: 16842599 [TBL] [Abstract][Full Text] [Related]
6. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity. Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835 [TBL] [Abstract][Full Text] [Related]
7. Epitope spreading is rarely found in pemphigus vulgaris by large-scale longitudinal study using desmoglein 2-based swapped molecules. Ohyama B; Nishifuji K; Chan PT; Kawaguchi A; Yamashita T; Ishii N; Hamada T; Dainichi T; Koga H; Tsuruta D; Amagai M; Hashimoto T J Invest Dermatol; 2012 Apr; 132(4):1158-68. PubMed ID: 22277941 [TBL] [Abstract][Full Text] [Related]
8. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies. Hacker MK; Janson M; Fairley JA; Lin MS Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995 [TBL] [Abstract][Full Text] [Related]
9. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells. Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957 [TBL] [Abstract][Full Text] [Related]
10. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1. Hashimoto T; Amagai M; Garrod DR; Nishikawa T Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919 [TBL] [Abstract][Full Text] [Related]
11. A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris. Zagorodniuk I; Weltfriend S; Shtruminger L; Sprecher E; Kogan O; Pollack S; Bergman R Int J Dermatol; 2005 Jul; 44(7):541-4. PubMed ID: 15985020 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446 [TBL] [Abstract][Full Text] [Related]
13. The desmosome and hemidesmosome in cutaneous autoimmunity. Lin MS; Mascaró JM; Liu Z; España A; Diaz LA Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929 [TBL] [Abstract][Full Text] [Related]
14. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes. Cirillo N; Femiano F; Gombos F; Lanza A Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441 [TBL] [Abstract][Full Text] [Related]
15. Cutaneous type pemphigus vulgaris: a rare clinical phenotype of pemphigus. Yoshida K; Takae Y; Saito H; Oka H; Tanikawa A; Amagai M; Nishikawa T J Am Acad Dermatol; 2005 May; 52(5):839-45. PubMed ID: 15858475 [TBL] [Abstract][Full Text] [Related]
16. Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus. Ohyama M; Amagai M; Hashimoto T; Nousari HC; Anhalt GJ; Nishikawa T J Am Acad Dermatol; 2001 Apr; 44(4):593-8. PubMed ID: 11260531 [TBL] [Abstract][Full Text] [Related]
17. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity. Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345 [TBL] [Abstract][Full Text] [Related]
18. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754 [TBL] [Abstract][Full Text] [Related]
19. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes. Cirillo N; Femiano F; Gombos F; Lanza A FEBS Lett; 2006 May; 580(13):3276-81. PubMed ID: 16698018 [TBL] [Abstract][Full Text] [Related]
20. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris. Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]